| 000 | 01726 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250515211217.0 | ||
| 264 | 0 | _c20100414 | |
| 008 | 201004s 0 0 eng d | ||
| 022 | _a1469-4409 | ||
| 024 | 7 |
_a10.1017/S0950268810000464 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLloyd-Smith, E | |
| 245 | 0 | 0 |
_aCommunity-associated methicillin-resistant Staphylococcus aureus is prevalent in wounds of community-based injection drug users. _h[electronic resource] |
| 260 |
_bEpidemiology and infection _cMay 2010 |
||
| 300 |
_a713-20 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xpharmacology |
| 650 | 0 | 4 |
_aBacterial Toxins _xgenetics |
| 650 | 0 | 4 |
_aCommunity-Acquired Infections _xepidemiology |
| 650 | 0 | 4 | _aComorbidity |
| 650 | 0 | 4 | _aDrug Users |
| 650 | 0 | 4 |
_aExotoxins _xgenetics |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLeukocidins _xgenetics |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMethicillin Resistance |
| 650 | 0 | 4 |
_aMethicillin-Resistant Staphylococcus aureus _xisolation & purification |
| 650 | 0 | 4 | _aMicrobial Sensitivity Tests |
| 650 | 0 | 4 | _aPrevalence |
| 650 | 0 | 4 |
_aStaphylococcal Infections _xepidemiology |
| 650 | 0 | 4 |
_aSubstance Abuse, Intravenous _xcomplications |
| 650 | 0 | 4 |
_aWound Infection _xepidemiology |
| 700 | 1 | _aHull, M W | |
| 700 | 1 | _aTyndall, M W | |
| 700 | 1 | _aZhang, R | |
| 700 | 1 | _aWood, E | |
| 700 | 1 | _aMontaner, J S G | |
| 700 | 1 | _aKerr, T | |
| 700 | 1 | _aRomney, M G | |
| 773 | 0 |
_tEpidemiology and infection _gvol. 138 _gno. 5 _gp. 713-20 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1017/S0950268810000464 _zAvailable from publisher's website |
| 999 |
_c19569740 _d19569740 |
||